Arrhythmia in Children
Conditions
Brief summary
Specific Aim #1 - To determine the accuracy of Apple Watch ECG tracings heart rate in children. Specific Aim #2 - To determine if extended monitoring with the Apple Watch can identify arrhythmia events that were not detected by short term clinical monitoring.
Interventions
Wearable monitor for heart rate and arrhythmia detection
Sponsors
Study design
Eligibility
Inclusion criteria
* All pediatric patients age 6 - 21 years undergoing clinically indicated arrhythmia monitoring * Patients with developmental ability (as determined by patient and parents) to safely wear the Apple Watch and utilize the patient activated trigger buttons on both the clinical monitor and the Apple Watch.
Exclusion criteria
* Age \< 6 years. Those under 6 many not be able to safely use the watch and have the developmental ability (as gauged by clinician and parents) to utilize the trigger features on the watch and cardiac rhythm monitor. * Inability to effectively utilize the triggered features of the monitor or watch * Patients unable to utilize the Apple Watch.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Heart rate correlation | Up to 2 weeks | Comparison of heart rate (bpm) between the Apple Watch and standard clinical rhythm monitor |
| Arrhythmia correlation | Up to 6 months | Comparison of the number of clinically significant arrhythmia events between the Apple Watch and standard clinical rhythm monitor. Clinically significant arrhythmia events include supraventricular arrhythmias, ventricular arrhythmias, sinus pauses, and conduction abnormalities/heart block |
Countries
United States